The Rush Inherited Susceptibility to Cancer (RISC) Program counsels people on their personal and family risks for developing cancer, and provides information on prevention and early detection.

Recent studies have shown that women who test positive for one of two genetic mutations have an 85 percent chance of developing breast or ovarian cancer by the time they turn 70. Through the RISC program, Rush physicians check women for these two genetic mutations (BRCA1 and BRCA2) using a simple blood test. Pre- and post-test counseling are provided, as well as education for women with other breast cancer risks, such as a strong family history of the disease.

Director: Lydia Usha, MD
Genetic Nurse Clinician: Dianne Chapman, ND, RN, NP-C
Medical Oncologist: Lydia Usha, MD
Molecular Biologist: John Coon, MD, PhD